LXRX
Lexicon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.24
−0.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 56.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.71x
- Price / sales
- 24.03x
- Price / cash flow
- -12.50x
Enterprise value
- Enterprise value
- $865.4M
- EV / sales
- 20.87x
- EV / EBITDA
- -16.56x
- EV / EBIT
- -15.88x
- Market cap
- $996.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026